HIV protease inhibitors-induced atherosclerosis: Prevention by α-tocopherol

IUBMB Life

Volumn 56, Issue 10, 2004, Pages 629-631

  Munteanu, Adelina ^a   Ricciarelli, Roberta ^b   Zingg, Jean Marc ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Atherosclerosis; CD36; Proteasome; Ritonavir; Scavenger receptor; Tocopherol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CD36 ANTIGEN; PROTEINASE INHIBITOR; RITONAVIR; SCAVENGER RECEPTOR;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG INDUCED DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; MONOCYTE; RISK FACTOR; UBIQUITINATION; UPREGULATION;

ALPHA-TOCOPHEROL; ANTIGENS, CD36; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SEPARATION; CHOLESTEROL; FLOW CYTOMETRY; HIV PROTEASE INHIBITORS; HUMANS; PHOSPHOLIPIDS; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RITONAVIR; UBIQUITIN; UP-REGULATION; VITAMIN E;

EID: 15244357264     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540400020387     Document Type: Article

References (11)

1. Periard, D., Telenti, A., Sudre, P., Cheseaux, J. J., Halfon, P., Reymond, M. J., Marcovina, S. M., Glauser, M. P., Nicod, P., Darioli, R., and Mooser, V. (1999) Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 100, 700-705.
2. Dressman, J., Kincer, J., Matveev, S. V., Guo, L., Greenberg, R. N., Guerin, T., Meade, D., Li, X. A., Zhu, W., Uittenbogaard, A., et al. (2003) HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J. Clin. Invest. 111, 389-397.
3. Zingg, J. M., Ricciarelli, R., and Azzi, A. (2000) Scavenger receptor regulation and atherosclerosis. Biofactors 11, 189-200.
4. Ricciarelli, R., Zingg, J. M., and Azzi, A. (2000) Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured human aortic smooth muscle cells. Circulation 102, 82-87.
5. Munteanu, A., Zingg, J. M., Ogru, E., Libinaki, R., Gianello, R., West, S., Negis, Y., and Azzi, A. (2004) Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Biochem. Biophys. Res. Commun. 318, 311-316.
6. Goppelt, M., and Resch, K. (1984) Densitometric quantitation of individual phospholipids from natural sources separated by one-dimensional thin-layer chromatography. Anal. Biochem. 140, 152-156.
7. Kempna, P., Zingg, J. M., Ricciarelli, R., Hierl, M., Saxena, S., and Azzi, A. (2003) Cloning of novel human SEC14p-like proteins: cellular localization, ligand binding and functional properties. Free Radic. Biol. Med. 34, 1458-1472.
8. Ruiz, J. I., and Ochoa, B. (1997) Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis. J. Lipid. Res. 38, 1482-1489.
9. Rodgers, K. J., and Dean, R. T. (2003) Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates. Int. J. Biochem. Cell Biol. 35, 716-727.
10. Andre, P., Groettrup, M., Klenerman, P., de Giuli, R., Booth, B. L., Jr., Cerundolo, V., Bonneville, M., Jotereau, F., Zinkernagel, R. M., and Lotteau, V. (1998) An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA 95, 13120-13124.
11. Hui, D. Y. (2003) HIV protease inhibitors and atherosclerosis. J. Clin. Invest. 111, 317-318.